International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-2 doi: 10.5281/zenodo.15067091
Original Article
Unveiling the Risk: Age, Diabetes, HTN and BMI as Predictors of Atherosclerosis in Postmenopausal Women
 ,
 ,
 ,
 ,
 ,
Published
March 21, 2025
Abstract

This study aimed to predict atherosclerosis in menopausal women based on independent variables such as age, diabetes mellitus (DM), hypertension (HTN), and body mass index (BMI). A total of 105 postmenopausal women attending the gynaecology outpatient department at SMS Medical College, Jaipur, were included in this observational study. Carotid intima-media thickness (cIMT) was measured using ultrasound to assess subclinical atherosclerosis. The results indicated that age, DM, HTN, and BMI were significant predictors of increased cIMT. Women with higher BMI, diabetes, and hypertension had significantly greater cIMT values, suggesting a higher risk of atherosclerosis. This study highlights the importance of early screening and management of these risk factors to prevent cardiovascular diseases in menopausal women.

Recommended Articles
Loading Image...
Volume-6, Issue-2
Citations
1334 Views
221 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved